세계의 항구토제 시장 규모 조사 및 예측 : 약물 유형별, 용도별, 유통 채널별, 지역별 분석(2023-2030년)

Global Antiemetics Market is valued at approximately USD 2.44 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2023-2030. Antiemetics is a group of drugs used to treat or prevent nausea and vomiting, which are frequent side effects of many different medical illnesses, treatments, and drugs. An antiemetic is a type of medication that lessens nausea and vomiting. The adverse effects of opioid analgesics, general anesthetics, and chemotherapy are frequently treated with them. It is used to treat conditions including motion sickness, pregnancy, food poisoning, and dizziness in patients. The growing prevalence of nausea and vomiting, surge in research and development activities and identification of new drug targets, increasing healthcare expenditure, and rising health consciousness among people, coupled with the rising number of hospitals are the key factors that are associated with the market growth during the estimated period.

The increasing prevalence of cancer and gastroenteritis worldwide is playing a vital role in bolstering the market demand across the globe. Chemotherapy and radiation therapy are standard treatments for cancer. However, these treatments often cause significant nausea and vomiting as side effects. The increasing adoption of these therapies, along with the need to effectively manage treatment-related symptoms, drives the demand for antiemetic medications. The GLOBOCAN stated that, in 2020, it was estimated that approximately 19.3 million new cases of cancer were reported globally and the figure is anticipated to rise to 30.2 million by 2040. Thus, these aforementioned factors are propelling the growth of the Antiemetics Market during the estimated period. Moreover, the rising technological advancements in drug delivery systems, as well as the expanded use of antiemetics in non-oncology settings present various lucrative opportunities over the forecast years. However, the less awareness about antiemetic drugs among the population and the unavailability of suitable animal models are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Antiemetics Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the rising inclination towards chemotherapy and radiation therapy, increasing focus on advancements in antiemetic drug development, and the presence of well-established market players. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. The growing geriatric population, increasing prevalence of nausea and vomiting, and expanded use of antiemetics in non-oncology settings are significantly propelling the market demand across the region.

Major market players included in this report are:

• Novartis AG
• GlaxoSmithKline Plc
• Cipla Limited
• Acacia Pharma Group Plc
• Dr. Reddy's Laboratories Ltd
• Sanofi
• Merck & Co. Inc
• Pfizer Inc
• Torrent Pharmaceuticals Ltd
• Johnson & Johnson Private Limited

Recent Developments in the Market:

• In February 2020, The US FDA approved Barhemsys from Acacia Pharmaceutical. A formulation of amisulpride (a dopamine antagonist) for intravenous administration is used to treat postoperative nausea and vomiting in individuals who failed to improve after receiving therapy with an antiemetic from a different class. Barhemsys is anticipated to go on sale in the second half of 2022, as the business is already making such preparations.

Global Antiemetics Market Report Scope:

• Historical Data: 2020 - 2021
• Base Year for Estimation: 2022
• Forecast period: 2023-2030
• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: Drug Type, Application, Distribution Channel, Region
• Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Drug Type:

• Antihistamines
• Serotonin Receptor Antagonists
• Dopamine Receptor Antagonists
• Neurokinin Receptor Antagonists
• Anticholinergics
• Other Drug Types

By Application:

• Chemotherapy
• Post Operative Surgery
• Pregnancy and Gatroenteritis
• Other Applications

By Distribution Channel:

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Antiemetics Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Antiemetics Market, by Drug Type, 2020-2030 (USD Billion)
  • 1.2.3. Antiemetics Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4. Antiemetics Market, by Distribution Channel, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Antiemetics Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Antiemetics Market Dynamics

• 3.1. Antiemetics Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing prevalence of cancer and gastroenteritis
    • 3.1.1.2. Surge in research and development activities and identification of new drug targets
  • 3.1.2. Market Challenges
    • 3.1.2.1. Less awareness about antiemetic drugs among the population
    • 3.1.2.2. Unavailability of suitable animal model
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising technological advancements in drug delivery systems
    • 3.1.3.2. Expanded use of antiemetics in non-oncology settings

Chapter 4. Global Antiemetics Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Antiemetics Market, by Drug Type

• 5.1. Market Snapshot
• 5.2. Global Antiemetics Market by Drug Type, Performance - Potential Analysis
• 5.3. Global Antiemetics Market Estimates & Forecasts by Drug Type 2020-2030 (USD Billion)
• 5.4. Antiemetics Market, Sub Segment Analysis
  • 5.4.1. Antihistamines
  • 5.4.2. Serotonin Receptor Antagonists
  • 5.4.3. Dopamine Receptor Antagonists
  • 5.4.4. Neurokinin Receptor Antagonists
  • 5.4.5. Anticholinergics
  • 5.4.6. Other Drug Types

Chapter 6. Global Antiemetics Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Antiemetics Market by Application, Performance - Potential Analysis
• 6.3. Global Antiemetics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Antiemetics Market, Sub Segment Analysis
  • 6.4.1. Chemotherapy
  • 6.4.2. Post Operative Surgery
  • 6.4.3. Pregnancy and Gatroenteritis
  • 6.4.4. Other Applications

Chapter 7. Global Antiemetics Market, by Distribution Channel

• 7.1. Market Snapshot
• 7.2. Global Antiemetics Market by Distribution Channel, Performance - Potential Analysis
• 7.3. Global Antiemetics Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
• 7.4. Antiemetics Market, Sub Segment Analysis
  • 7.4.1. Retail Pharmacies
  • 7.4.2. Hospital Pharmacies
  • 7.4.3. Online Pharmacies

Chapter 8. Global Antiemetics Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Antiemetics Market, Regional Market Snapshot
• 8.4. North America Antiemetics Market
  • 8.4.1. U.S. Antiemetics Market
    • 8.4.1.1. Drug Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Antiemetics Market
• 8.5. Europe Antiemetics Market Snapshot
  • 8.5.1. U.K. Antiemetics Market
  • 8.5.2. Germany Antiemetics Market
  • 8.5.3. France Antiemetics Market
  • 8.5.4. Spain Antiemetics Market
  • 8.5.5. Italy Antiemetics Market
  • 8.5.6. Rest of Europe Antiemetics Market
• 8.6. Asia-Pacific Antiemetics Market Snapshot
  • 8.6.1. China Antiemetics Market
  • 8.6.2. India Antiemetics Market
  • 8.6.3. Japan Antiemetics Market
  • 8.6.4. Australia Antiemetics Market
  • 8.6.5. South Korea Antiemetics Market
  • 8.6.6. Rest of Asia Pacific Antiemetics Market
• 8.7. Latin America Antiemetics Market Snapshot
  • 8.7.1. Brazil Antiemetics Market
  • 8.7.2. Mexico Antiemetics Market
• 8.8. Middle East & Africa Antiemetics Market
  • 8.8.1. Saudi Arabia Antiemetics Market
  • 8.8.2. South Africa Antiemetics Market
  • 8.8.3. Rest of Middle East & Africa Antiemetics Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Novartis AG
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. GlaxoSmithKline Plc
  • 9.3.3. Cipla Limited
  • 9.3.4. Acacia Pharma Group Plc
  • 9.3.5. Dr. Reddy's Laboratories Ltd
  • 9.3.6. Sanofi
  • 9.3.7. Merck & Co. Inc
  • 9.3.8. Pfizer Inc
  • 9.3.9. Torrent Pharmaceuticals Ltd
  • 9.3.10. Johnson & Johnson Private Limited

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption